ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesE71.30

E71.30

Billable

Disorder of fatty-acid metabolism, unspecified

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E71.30 is a billable code used to indicate a diagnosis of disorder of fatty-acid metabolism, unspecified.

Key Diagnostic Point:

Disorders of fatty-acid metabolism encompass a range of genetic and metabolic conditions that affect the body's ability to metabolize fatty acids properly. These disorders can lead to an accumulation of fatty acids in the body, resulting in various clinical manifestations, including hypoglycemia, muscle weakness, cardiomyopathy, and liver dysfunction. The specific enzyme deficiencies involved in these disorders can vary, leading to different clinical presentations and severity. Commonly affected enzymes include acyl-CoA dehydrogenases, which are crucial for the oxidation of fatty acids. Patients may present with symptoms such as fatigue, recurrent vomiting, and failure to thrive in infancy. Diagnosis often involves biochemical testing, including acylcarnitine profiling and urine organic acid analysis. Genetic testing may also be employed to identify specific mutations associated with the disorder. Due to the broad nature of this code, it is essential for coders to ensure that the documentation supports the diagnosis of a fatty-acid metabolism disorder, as the unspecified nature of the code may lead to ambiguity in clinical scenarios.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of underlying genetic conditions
  • Need for biochemical testing to confirm diagnosis
  • Potential overlap with other metabolic disorders
  • Variability in clinical presentation

Audit Risk Factors

  • Insufficient documentation of clinical symptoms
  • Lack of biochemical test results in the medical record
  • Inconsistent coding of related metabolic disorders
  • Failure to specify the type of fatty-acid metabolism disorder

Specialty Focus

Medical Specialties

Pediatrics

Documentation Requirements

Detailed clinical history, including growth parameters and symptomatology.

Common Clinical Scenarios

Infants presenting with failure to thrive or metabolic crises.

Billing Considerations

Documentation must include metabolic screening results and any genetic testing performed.

Genetics

Documentation Requirements

Genetic testing results and family history of metabolic disorders.

Common Clinical Scenarios

Patients with a family history of metabolic disorders undergoing evaluation.

Billing Considerations

Ensure that genetic counseling notes are included in the documentation.

Coding Guidelines

Inclusion Criteria

Use E71.30 When
  • Follow the official ICD
  • CM coding guidelines for metabolic disorders
  • Ensure that the documentation supports the diagnosis of a fatty
  • acid metabolism disorder and that any related conditions are coded appropriately

Exclusion Criteria

Do NOT use E71.30 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

81401CPT Code

Molecular pathology procedure

Clinical Scenario

Used when genetic testing is performed to confirm a fatty-acid metabolism disorder.

Documentation Requirements

Documentation of clinical indications for genetic testing.

Specialty Considerations

Genetic specialists should ensure comprehensive family history is documented.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including fatty-acid metabolism disorders. This specificity aids in better tracking of these conditions and improves the accuracy of healthcare data.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including fatty-acid metabolism disorders. This specificity aids in better tracking of these conditions and improves the accuracy of healthcare data.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including fatty-acid metabolism disorders. This specificity aids in better tracking of these conditions and improves the accuracy of healthcare data.

Resources

Clinical References

  • •
    National Organization for Rare Disorders (NORD)

Coding & Billing References

  • •
    National Organization for Rare Disorders (NORD)

Frequently Asked Questions

What are the common symptoms of fatty-acid metabolism disorders?

Common symptoms include hypoglycemia, muscle weakness, cardiomyopathy, and recurrent vomiting, particularly in infants and children.